Company Profile

Synactix Pharmaceuticals Inc
Profile last edited on: 11/2/18      CAGE: 74Y82      UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2014
First Award
2015
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9040 South Rita Road Suite 1270
Tucson, AZ 85747
   (800) 366-1752
   contact@synactixpharma.com
   www.synactixpharma.com
Location: Single
Congr. District: 02
County: 

Public Profile

Synactix Pharmaceuticals, Inc. is taking a different path towards addressing cancer as a whole. Synactix is focused to identifying specific malignant pathways in particular cancers that are amenable to therapeutic intervention. Using bioinformatics, pathways that are interdependent are identified and a single-agent is created that can block both pathways at the same therapeutic dose. Synactix has invented an effective strategy to block multiple, malignant pathways to decrease the frequency of resistant disease - practicing precision medicine through the strategic targeting of multiple-disease pathways with a single-agent.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Brendan A Frett -- Co-Founder and CEO

  Hong Yu Li

  Samantha Whitman

Company News

There are no news available.